Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
Condition: NK/T Cell Lymphoma Nos Intervention: Drug: sintilimab,pegaspargase,gemcitabine,oxaliplatin Sponsor: Sun Yat-sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials